Literature DB >> 29520419

[Extracorporeal shock wave lithotripsy].

J Klein1, C Netsch2, K D Sievert3, A Miernik4, J Westphal5, H Leyh6, T R W Herrmann7, P Olbert8, A Häcker9, A Bachmann10, R Homberg11, M Schoenthaler4, J Rassweiler12, A J Gross2.   

Abstract

Interventional treatment of stones essentially consists of three treatment modalities. Extracorporeal shockwave lithotripsy (ESWL), in addition to uterorenoscopy (URS) and percutaneous nephrolitholapaxy (PCNL) is an essential treatment pillar and is the only noninvasive therapy option for the treatment of urinary stones. After a long period of ESWL being the leading choice in stone treatment, the number of SWL interventions diminished in recent years in favor of the other two treatment modalities (URS and PCNL). This article describes the indications, surgical technique and management of complications of SWL.

Keywords:  Minimally invasive techniques; Stone treatment; Surgical techniques; Urinary calculi; Urolihiasis

Mesh:

Year:  2018        PMID: 29520419     DOI: 10.1007/s00120-018-0611-9

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  29 in total

Review 1.  Medical therapy to facilitate the passage of stones: what is the evidence?

Authors:  Christian Seitz; Evangelos Liatsikos; Francesco Porpiglia; Hans-Göran Tiselius; Ulrike Zwergel
Journal:  Eur Urol       Date:  2009-06-21       Impact factor: 20.096

Review 2.  Optimal frequency of shock wave lithotripsy in urolithiasis treatment: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Kaiwen Li; Tianxin Lin; Caixia Zhang; Xinxiang Fan; Kewei Xu; Liangkuan Bi; Jinli Han; Hai Huang; Hao Liu; Wen Dong; Yu Duan; Min Yu; Jian Huang
Journal:  J Urol       Date:  2013-03-26       Impact factor: 7.450

Review 3.  Medical Expulsive Therapy in Urolithiasis: A Review of the Quality of the Current Evidence.

Authors:  Andreas Skolarikos; Khurshid R Ghani; Christian Seitz; Brandon Van Asseldonk; Matthew F Bultitude
Journal:  Eur Urol Focus       Date:  2017-05-27

4.  Mechanical percussion, inversion and diuresis for residual lower pole fragments after shock wave lithotripsy: a prospective, single blind, randomized controlled trial.

Authors:  K T Pace; N Tariq; S J Dyer; M J Weir; R J D'A Honey
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

5.  A clinical nomogram to predict the successful shock wave lithotripsy of renal and ureteral calculi.

Authors:  Joshua D Wiesenthal; Daniela Ghiculete; A Andrew Ray; R John D'A Honey; Kenneth T Pace
Journal:  J Urol       Date:  2011-08       Impact factor: 7.450

Review 6.  Retrograde Intrarenal Surgery Versus Percutaneous Nephrolithotomy Versus Extracorporeal Shockwave Lithotripsy for Treatment of Lower Pole Renal Stones: A Meta-Analysis and Systematic Review.

Authors:  Wei Zhang; Tie Zhou; Tengyun Wu; Xiaofeng Gao; Yonghan Peng; Chuanliang Xu; Qi Chen; Ruixiang Song; Yinghao Sun
Journal:  J Endourol       Date:  2015-02-05       Impact factor: 2.942

Review 7.  Shock wave lithotripsy: advances in technology and technique.

Authors:  James E Lingeman; James A McAteer; Ehud Gnessin; Andrew P Evan
Journal:  Nat Rev Urol       Date:  2009-12       Impact factor: 14.432

8.  Low-frequency extracorporeal shock wave lithotripsy improves renal pelvic stone disintegration in a pig model.

Authors:  Rolf Gillitzer; Andreas Neisius; Jens Wöllner; Christian Hampel; Walburgis Brenner; Arturo Alvarado Bonilla; Joachim Thüroff
Journal:  BJU Int       Date:  2009-01-21       Impact factor: 5.588

Review 9.  Medical expulsive therapy as an adjunct to improve shockwave lithotripsy outcomes: a systematic review and meta-analysis.

Authors:  Trevor D Schuler; Rohan Shahani; R John D'A Honey; Kenneth T Pace
Journal:  J Endourol       Date:  2009-03       Impact factor: 2.942

10.  Extracorporeal shock wave lithotripsy today.

Authors:  Geert G Tailly
Journal:  Indian J Urol       Date:  2013-07
View more
  1 in total

1.  Trends in the treatment of urinary stone disease in Turkey.

Authors:  Kadir Yildirim; Mahmut Taha Olcucu; Muhammed Emre Colak
Journal:  PeerJ       Date:  2018-07-31       Impact factor: 2.984

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.